Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Natural honey protects against Doxorubicin's harmful effects.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Ruxolitinib can help regrow hair in severe alopecia areata.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

PTH-CBD helps reduce hair loss in mice by stimulating hair growth directly.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The apelinergic system might protect the heart from damage caused by doxorubicin.

CD98hc's role in skin health decreases with age.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Clascoterone may be a promising treatment for hair loss.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

The committee decided not to approve the drug due to low effectiveness and high risks.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.